Patrys Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Patrys şirketinin toplam hissedar öz sermayesi A$3.5M ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$4.2M ve A$691.4K dir.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	n/a
Nakit	AU$2.24m
Eşitlik	AU$3.47m
Toplam yükümlülükler	AU$691.37k
Toplam varlıklar	AU$4.16m

Son finansal sağlık güncellemeleri

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Sep 01

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

May 11

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

Sep 28

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Jun 15

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

Mar 01

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Jan 07

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PAB 'nin kısa vadeli varlıkları ( A$3.8M ) kısa vadeli yükümlülüklerini ( A$688.7K ) aşıyor.

Uzun Vadeli Yükümlülükler: PAB şirketinin kısa vadeli varlıkları ( A$3.8M ) uzun vadeli yükümlülüklerini ( A$2.6K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PAB borçsuzdur.

Borcun Azaltılması: PAB son 5 yıldır borcu bulunmamaktadır.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: PAB şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: PAB un, serbest nakit akışı her yıl % 20.3 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Patrys Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Recent updates

Patrys Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2023)

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin